Epidemiological update: outbreak of hepatitis A virus infection in four Nordic countries
As of 6 August 2013, the Danish, Finnish, Norwegian and Swedish public health institutes reported 106 cases associated with the hepatitis A virus (HAV) infection outbreak affecting their countries since 1 October 2012. Of these, 64 were confirmed and 42 were probable.
Outbreak of hepatitis A continues – ECDC/EFSA update assessment
Viral hepatitis: testing saves lives
Every year, around 50 000 newly diagnosed cases of hepatitis B and C are reported across Europe but millions are unaware of their infection. Left untreated, hepatitis can cause irreversible liver damage. Hepatitis A is recognised as a re-emerging health threat in Europe.
Vaccination: main prevention measure to address hepatitis A outbreaks among men who have sex with men
1 173 confirmed hepatitis A cases involving three separate clusters have been reported across 15 countries of the European Union since June 2016. Several EU countries have seen large increases in hepatitis A cases in 2017 compared to previous years, and these are mainly affecting men who have sex with men.
Taking stock: where does Europe stand in the elimination of hepatitis B and C?
In 2016, a regional action plan for Europe that aims to contribute to the implementation of the global viral hepatitis elimination strategy was developed by the WHO Regional Office for Europe. In an article published today in Eurosurveillance, the authors take a closer look how Europe is doing according to the ten indicators and targets outlined in this plan. In short: Europe still has some way to go if it wants to eliminate viral hepatitis by 2030.
Epidemiological update: Hepatitis A outbreaks in the EU/EEA mostly affecting men who have sex with men
Since the last ECDC rapid risk assessment, which was published on 24 February 2017, 10 EU Member States (Austria, Belgium, Denmark, France, Germany, Italy, the Netherlands, Portugal, Sweden and the United Kingdom (Public Health England and Health Protection Scotland) reported 387 new confirmed cases of hepatitis A, with one of the strains matching the three clusters currently circulating in the EU.
EMCDDA and ECDC join forces to address the challenge of hepatitis
Hepatitis and other drug-related infectious diseases will be the focus of ‘Hepatitis week’, taking place at the EU drugs agency (EMCDDA) in Lisbon from 12–16 June 2017. The initiative will bring together some 100 specialists from: EU Member States, candidate and potential candidate countries to the EU, as well as partner agencies, civil society and professional organisations.